An experimental study was conducted before and after injection of anti-EGFR -MPB using 2 filter modes to image blood vessels (532 to 1,000 nm) and the nanocomposite to evaluate the impacts of anti-EGFR-MPB (625 to 1,000 nm) on tumor-specific binding affinity. The gene discussed is EGFR; the disease is neoplasm.